{
    "medicine_id": "50768767be6fbfb5dad1f55d8316d8d54b95b157",
    "platform_id": "DB09340",
    "metadata": {
        "name": "Air 1000 mL 1L Gas",
        "composition": "1000 mL 1L Tyropanoic acid",
        "clinical_particulars": {
            "therapeutic_indications": "For use in cholecystography X ray diagnosis imaging of gallstones",
            "contraindications": {
                "disease": "LD50 i v in mice 720 mg kg L1605 Since the introduction of iopanoic acid Telepaque in 1951 widespread clinical application has demonstrated that this medium represents an ideal cholecystographic agent 1 Iopanoic acid \u03b2 3 amino 2 4 6 triiodophenyl \u03b1 ethylpropionic acid contains 66 68 iodine Maximum concentration in the gallbladder occurs at from 10 to 12 hours Iopanoic acid is excreted primarily through the intestinal tract Its elimination is rapid and complete within 48 hours Toxic reactions to this agent are rare and side effects rarely occur L1608 Although the foregoing oral cholecystographic agents are relatively non toxic substances adverse reactions such as minor gastrointestinal disturbances or allergic reactions are occasionally observed Therefore it is highly desirable in order to minimize the occurrence of these undesirable side effects to use as low a dose as possible and maintain the blood plasma iodine concentration at the lowest possible level without sacrificing adequate imaging of the gallbladder L1610 A study was done on this agent in basic form and slow release form L1610 The acute oral toxicity in mice of the basic formulation was determined and a 7 day LD50 value of 5042 3623 6596 mg kg in terms of sodium tyropanoate was obtained This compared to a Ld50 value of 3158 1302 3900 for commercial sodium tyropanoate capsule mix uncoated The sustained release preparation was thus statistically significantly less toxic than the immediate release material L1610",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Tyropanoate sodium also known as sodium tyropanoate is a radiocontrast agent used in cholecystography X ray imagining and diagnosis of gallstones This molecule contains three heavy iodine atoms which obstruct X rays to produce a visible image After injection it is rapidly excreted into the bile L1607 L1608 L1609",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}